Attralus set for amyloidosis asset’s European orphan designations
EMA’s COMP has adopted positive opinions for two orphan medicinal product designations for Attralus’s AT-02.
EMA’s COMP has adopted positive opinions for two orphan medicinal product designations for Attralus’s AT-02.
What's Your Reaction?
